CD34 and acute myeloid leukemia: To better understand the metabolic state of leukemic cells with high mtDNAc, we performed an unsupervised label-free quantitative proteome (n = 30) analysis of CD34+ sorted cells (or CD117+, for CD34- samples) from AML patients with different levels of mtDNAc using LC-MS.